Related Experiment Video
Updated: Jun 13, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
NME2 modulates HCC progression through 4EBP1 phosphorylation and autophagy regulation independent of mTOR
Wei Chen1, Da-Chen Zhou2, Chen-Hui Rui2
1Department of General Surgery, The Second People's Hospital of Hefei, Anhui, China.
Background:
To investigate the role of nucleoside diphosphate kinase 2 (NME2) in HCC progression, assessing its therapeutic potential.
Methods:
Utilizing transcriptome sequencing data from The Cancer Genome Atlas (TCGA) and immunohistochemical staining of tissue microarrays, we analyzed NME2 expression in HCC tumor tissues. The effects of NME2 on HCC cell proliferation and autophagy flux were assessed through knockdown and overexpression experiments. Additionally, the relationship between NME2 and 4EBP1 phosphorylation was explored through specific site mutation analysis.
Results:
NME2 overexpression in HCC correlated with poor prognosis. NME2 knockdown significantly hindered HCC cell proliferation and induced autophagy flux. Notably, NME2 modulates 4EBP1 phosphorylation (Thr37/46) independently of mTOR, unveiling a novel axis in HCC pathogenesis. Additionally, NME2 modulates eukaryotic translation initiation factor 4F (eIF4F) complex formation and autophagy flux.
Conclusions:
NME2 plays a crucial role in HCC development by modulating 4EBP1 phosphorylation and autophagy through an mTOR-independent pathway. Our research underscores NME2's significance as a potential therapeutic target in HCC, meriting further exploration of its underlying mechanisms and clinical applicability.
Insights
Nucleoside diphosphate kinase 2 (NME2) drives hepatocellular carcinoma (HCC) progression by affecting 4EBP1 phosphorylation and autophagy. Targeting NME2 offers a potential therapeutic strategy for HCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Understanding novel molecular drivers of HCC progression is critical for developing effective therapies.
Purpose of the Study:
- To investigate the role of nucleoside diphosphate kinase 2 (NME2) in HCC.
- To assess the therapeutic potential of targeting NME2 in HCC.
Main Methods:
- Analysis of NME2 expression using TCGA transcriptome data and immunohistochemistry.
- Assessment of NME2's impact on HCC cell proliferation and autophagy via knockdown/overexpression.
- Exploration of the NME2-4EBP1 phosphorylation relationship using site-specific mutations.
Main Results:
- NME2 overexpression correlates with poor prognosis in HCC patients.
- NME2 knockdown inhibits HCC cell proliferation and induces autophagy.
- NME2 modulates 4EBP1 phosphorylation (Thr37/46) independently of mTOR, impacting eIF4F complex formation and autophagy.
Conclusions:
- NME2 is a key regulator of HCC development through mTOR-independent modulation of 4EBP1 phosphorylation and autophagy.
- NME2 represents a promising therapeutic target for HCC.
- Further research is warranted to explore NME2's mechanisms and clinical applications in HCC.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Mitogens and the Cell Cycle
Master Transcription Regulators